R&D in Aptus
Is our priority to invest in research and development in aptamer technology. Our R&D activities are focused in developing and implementing specific biotechnological applications, where the aptamer technology brings an added value.
The R & D of Aptus is based on high quality science and technology supported by reference research centers, especially in the Laboratory of Aptamers of the IRYCIS.
We also seek to develop innovative applications that add value to the end user market. We collaborate with companies and market operators to provide useful and cost effective solutions using the aptamer technology.